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T HE Berlin definition of acute respiratory distress syn-drome (ARDS) categorizes patients with partial pres-
sure of arterial blood oxygen content to inspired fraction 
of oxygen (PaO2/fraction of inspired oxygen [FIO2]) ranging 
from 200 to 300 mmHg as “mild ARDS.”1 In the preceding 
American European Consensus Conference, this population 
was defined as having “non-ARDS acute lung injury.”2 Some 
clinicians continue to overlook these less severely hypoxemic 
patients and instead pay closer attention to patients they 
consider to have “actual” ARDS (i.e., moderate and severe 
ARDS groups). This group has not been included in some 
recent studies recruiting patients with ARDS.3–6 Patients 
Editor’s Perspective
What We Already Know about This Topic
• Hospital mortality in acute respiratory distress syndrome is 
approximately 40%, but mortality and trajectory in “mild” acute 
respiratory distress syndrome (classified only since 2012) are 
unknown, and many cases are not detected
What This Article Tells Us That Is New
• Approximately 80% of cases of mild acute respiratory distress 
syndrome persist or worsen in the first week; in all cases, the 
mortality is substantial (30%) and is higher (37%) in those in 
whom the acute respiratory distress syndrome progresses
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ABSTRACT
Background: Patients with initial mild acute respiratory distress syndrome are often underrecognized and mistakenly con-
sidered to have low disease severity and favorable outcomes. They represent a relatively poorly characterized population that 
was only classified as having acute respiratory distress syndrome in the most recent definition. Our primary objective was to 
describe the natural course and the factors associated with worsening and mortality in this population.
Methods: This study analyzed patients from the international prospective Large Observational Study to Understand the 
Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) who had initial mild acute respiratory distress syndrome 
in the first day of inclusion. This study defined three groups based on the evolution of severity in the first week: “worsening” 
if moderate or severe acute respiratory distress syndrome criteria were met, “persisting” if mild acute respiratory distress syn-
drome criteria were the most severe category, and “improving” if patients did not fulfill acute respiratory distress syndrome 
criteria any more from day 2.
Results: Among 580 patients with initial mild acute respiratory distress syndrome, 18% (103 of 580) continuously improved, 
36% (210 of 580) had persisting mild acute respiratory distress syndrome, and 46% (267 of 580) worsened in the first week 
after acute respiratory distress syndrome onset. Global in-hospital mortality was 30% (172 of 576; specifically 10% [10 of 
101], 30% [63 of 210], and 37% [99 of 265] for patients with improving, persisting, and worsening acute respiratory distress 
syndrome, respectively), and the median (interquartile range) duration of mechanical ventilation was 7 (4, 14) days (specifi-
cally 3 [2, 5], 7 [4, 14], and 11 [6, 18] days for patients with improving, persisting, and worsening acute respiratory distress 
syndrome, respectively). Admissions for trauma or pneumonia, higher nonpulmonary sequential organ failure assessment 
score, lower partial pressure of alveolar oxygen/fraction of inspired oxygen, and higher peak inspiratory pressure were inde-
pendently associated with worsening.
Conclusions: Most patients with initial mild acute respiratory distress syndrome continue to fulfill acute respiratory dis-
tress syndrome criteria in the first week, and nearly half worsen in severity. Their mortality is high, particularly in patients 
with worsening acute respiratory distress syndrome, emphasizing the need for close attention to this patient population. 
( Anesthesiology 2018; XXX:00-00)
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with mild ARDS have better unadjusted outcomes than 
patients with more severe hypoxemia in terms of ventilator-
free days, lengths of stay in the intensive care unit and in 
the hospital, and mortality.7–11 Nevertheless, intensive care 
unit and hospital mortality of this group of patient remains 
as high as 40%,7,11–13 emphasizing the need to better under-
stand this patient cohort.
To date, the Large Observational Study to Understand the 
Global Impact of Severe Acute Respiratory Failure (LUNG 
SAFE) is the largest prospective study having collected data 
on patients with ARDS according to the Berlin definition.7 
Almost one third of the 2,377 patients fulfilling the criteria 
for ARDS within 48 h of respiratory failure initially had mild 
ARDS at first assessment. Recent research showed different 
subphenotypes of patients with ARDS had distinct presen-
tations and outcomes,4,14 and autopsy studies showed that 
patients with mild ARDS displayed different histologic fea-
tures with a lower proportion of diffuse alveolar damage.15,16
We hypothesized that patients presenting with mild 
ARDS constitute a heterogeneous group with diverse evo-
lutions, and that in this group, the evolution in the first 
week after ARDS onset would be associated with patient 
outcome. Our primary objective was to characterize patients 
with initial mild ARDS and to describe their management, 
their evolution over the first week of critical illness, and their 
outcomes. Secondary objectives included identifying factors 
associated with progression to a more severe ARDS category, 
as well as factors associated with hospital mortality.
Materials and Methods
Study Design
LUNG SAFE (ClinicalTrials.gov identifier NCT02010073) 
was an international multicenter prospective observational 
study performed in 2014 that recruited nearly 13,000 patients 
from 459 intensive care units from 50 different countries. A 
total of 4,499 patients had acute respiratory hypoxemic failure 
defined by a PaO2/FIO2 of 300 mmHg or less, new pulmonary 
infiltrates on chest imaging, and ventilator support with a posi-
tive end-expiratory pressure (PEEP) of 5 cm H2O or more. 
Among them, 3,022 patients presented the Berlin criteria for 
ARDS during their intensive care unit stay. The present study 
was designed after LUNG SAFE data collection, but the analy-
sis and the different groups were planned before starting the 
data analyzing. The detailed methods and design of LUNG 
SAFE have previously been described,7 and further details are 
available in the Supplemental Digital Content (http://links.
lww.com/ALN/B814). Some of the results of this study have 
been previously reported in the form of abstracts.17
Participants
We included intubated patients with mild ARDS on the first day 
they fulfilled ARDS criteria and within the first 2 days of fulfill-
ing criteria for acute respiratory hypoxemic failure. Patients ini-
tially managed with noninvasive ventilation and not intubated 
in the first 2 days were excluded. We excluded patients based on 
the following criteria: (1) patients transferred to a participating 
intensive care unit more than 2 days after being admitted in 
another intensive care unit; (2) patients not present in the par-
ticipating intensive care unit the day after meeting criteria for 
mild ARDS; (3) patients with a decision to limit life-sustaining 
treatment in the first 2 days; and (4) patients treated with extra-
corporeal membrane oxygenation in the first 2 days of ARDS.
Definitions
On days 2, 3, 5, and 7 after the patient fulfilled criteria for 
mild ARDS, we assessed PaO2/FIO2 and patients’ ventilatory 
interface to define the following variables:
-  Improving: the worst PaO2/FIO2 available on days 2, 3, 5, 
and 7 was more than 300 mmHg
-  Persisting: the worst PaO2/FIO2 available on days 2, 3, 5, 
and 7 was more than 200 mmHg but 300 mmHg at most
-  Worsening: the worst PaO2/FIO2 available on days 2, 3, 5, 
and 7 was 200 mmHg at most
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To determine the factors associated with worsening oxy-
genation in the first week after mild ARDS onset, we also 
dichotomized patients into “worsening in the first week” ver-
sus all other patients (i.e., combination of the persisting and 
improving groups). When items for sequential organ failure 
assessment score calculations were missing, the missing values 
were omitted, and the denominator was adjusted accordingly.
Statistical Analysis
Continuous variables are reported as means ± SD or median 
(first, third quartiles), and categorical variables as count and 
proportion. Normality of the data distribution was visually 
assessed by means of histograms. Comparisons of propor-
tions were made using chi-square and Fisher exact tests. 
Continuous variables were compared using Student’s t tests 
or Wilcoxon rank sum test when two groups were compared; 
using paired Student’s t test or paired Wilcoxon rank sum 
test when variables were compared at two time points in the 
same group; and one-way ANOVA or Kruskal–Wallis tests 
when more than two groups were compared, as appropriate. 
Tukey’s range tests were then used to compare all possible 
pairs of means within the three groups.
We performed bivariate analyses to identify factors poten-
tially associated with the worsening group and with hospital 
mortality. We assumed that patients discharged alive from 
hospital before 90 days were alive on day 90. To determine 
the association of statistically significant variables with the out-
comes of interest while controlling for confounders, covariates 
found to be associated with the dependent variable (worsening 
group or hospital mortality) in the bivariate analysis with a P 
value less than or equal to 0.20 were entered in stepwise (for-
ward and backward) multivariable logistic regression analyses 
with significance α levels of 0.05 or less for retention. Multicol-
linearity was assessed calculating a variance inflation factor of 
each variable and ruled out if the variance inflation factor was 
lower than 4. The results are shown as odds ratios with 95% 
CI, and models’ performance was assessed using the Hosmer–
Lemeshow goodness-of-fit test statistic. We computed Kaplan–
Meier analysis to estimate the likelihood of hospital mortality 
within 90 days of onset of ARDS. To check the validity of the 
logistic regression to determine factors associated with hospital 
mortality, a Cox proportional hazard model and a time-varying 
Cox model (taking into account the subjects’ variability over 
time) were performed as sensitivity analyses.
No statistical power calculation was conducted before the 
study, and sample size was based on available data. For all 
numerical variables, outliers were assessed and corrected by 
contacting site investigators if needed. The remaining outli-
ers were plausible values that were kept in the analysis. No 
assumptions were made for missing data, and we followed the 
Strengthening the Reporting of Observational Studies in Epi-
demiology (STROBE) recommendations.18 Statistical analy-
ses were done with R (version 3.5.1, http://cran.r-project.org, 
accessed July 2018). All P values were two-sided, and values 
less than 0.05 were deemed statistically significant. The study 
protocol and case-report form, as well as additional methodo-
logic information, are in the Supplemental Digital Content 
(http://links.lww.com/ALN/B814).
Results
Patient Characteristics
The Berlin definition of ARDS at day 1 or 2 of acute respira-
tory hypoxemic failure was fulfilled by 2,377 of the 12,906 
patients enrolled in the LUNG SAFE study: 714 had mild 
ARDS, 1,106 had moderate ARDS, and 557 had severe 
ARDS. Of the 714 patients with mild ARDS, 693 were still 
present in the intensive care unit on the day after fulfilling 
ARDS criteria, and 601 did not have any of the prespecified 
exclusion criteria (fig.  1). Characteristics and outcomes of 
patients discharged from the participating intensive care unit 
before day 2 are presented in table 1 in the Supplemental 
Digital Content (http://links.lww.com/ALN/B814). Because 
of missing data, 21 additional patients could not be clas-
sified. Finally, a total of 580 patients were included in the 
analyses, and their main characteristics, ventilator manage-
ment, and outcomes are presented in table 1 and in table 
2 in the Supplemental Digital Content (http://links.lww.
com/ALN/B814). Their mean PaO2/FIO2 at ARDS onset was 
246 ± 28 mmHg, and 92% (529 of 577) were still intubated 
the day after fulfilling mild ARDS. Half of them were rec-
ognized by clinicians as having ARDS. Their median (inter-
quartile range) lengths of stay in the intensive care unit and 
in the hospital were, respectively, 11 (6, 19) and 19 (11, 37) 
days, whereas hospital mortality was 30% (172 of 576).
Comparison According to the Evolution in the First Week
Based on the worst evolution category in the first 7 days 
after the onset of ARDS, 18% (103 of 580) showed only 
improvement, 36% (210 of 580) remained stable, and 46% 
(267 of 580) worsened at least 1 day in the first 7 days after 
mild ARDS onset (table 1; table 2 in the Supplemental Digi-
tal Content, http://links.lww.com/ALN/B814). The rate of 
pneumonia differed among the three groups (P  =  0.008), 
being highest in patients from the worsening group com-
pared to each other group (56% vs. 47%, P  =  0.047 for 
comparison with the persisting group and 56% vs. 39%, 
P = 0.003 for comparison with the improving group).
Within each group, comparing PaO2/FIO2 from one day 
to the following day of data collection, the only differences 
were between the day of ARDS onset and the next day (P < 
0.001 for each group) and for the improving group between 
days 5 and 7 (tables 2 and 3 in the Supplemental Digital 
Content, http://links.lww.com/ALN/B814; table  4); after 
day 2, PaO2/FIO2 remained stable in the worsening group 
(fig 2A; tables 2 and 3 in the Supplemental Digital Con-
tent, http://links.lww.com/ALN/B814). Tidal volumes of 
mechanically ventilated patients remained stable over the 
first week of evolution and did not differ between the differ-
ent evolution groups (tables 2–4 in the Supplemental Digi-
tal Content, http://links.lww.com/ALN/B814; fig.  2B). 
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Respectively, 61% (338 of 550), 80% (438 of 550), and 
89% (492 of 550) of the patients had tidal volume of less 
than 8, 9, and 10 ml/kg of predicted body weight. Each 
day, PEEP settings were overall different between groups 
with the use of a higher PEEP in the group with worsen-
ing ARDS (fig. 2C; tables 2–4 in the Supplemental Digital 
Content, http://links.lww.com/ALN/B814).
In the worsening ARDS group, the first day with PaO2/
FIO2 of less than 200 mmHg was day 2 for 149 (56%), day 3 
for 53 (20%), day 5 for 40 (15%), and day 7 for 25 patients 
(9%). To determine the factors associated with worsening of 
mild ARDS, we compared the group worsening to the other 
patients (i.e., improving and persisting mild ARDS); the results 
are shown in table 2. Patients in the worsening group had a 
higher rate of medical (71% vs. 63%, P = 0.038) and trauma 
causes for admission (9% vs. 4%, P = 0.029) and a lower rate 
of surgical causes (21% vs. 33%, P < 0.001), whereas more of 
these patients had pneumonia as a risk factor (56% vs. 43%, 
P = 0.006), and they had a significantly lower initial PaO2/FIO2, 
higher PEEP, and higher peak inspiratory pressure (table 2). In 
a multivariable logistic regression including data collected on 
the first day of ARDS, only admission for trauma, pneumonia 
as a risk factor for ARDS, higher nonpulmonary sequential 
organ failure assessment score, lower initial PaO2/FIO2, and 
higher peak inspiratory pressures were independently associ-
ated with higher risk of worsening in the 7 days after mild 
ARDS onset (table 3). The model showed good fit (P = 0.183 
on the Hosmer–Lemeshow goodness-of-fit test).
Comparison According to Hospital Mortality
Of 580 patients with initial mild ARDS, 142 died in the 
intensive care unit (24.5%), and an additional 30 patients 
died in the hospital after intensive care unit discharge, 
resulting in total hospital mortality of 29.9% (272 of 576). 
Fig. 1. Flowchart. This figure shows the patient selection process for inclusion in the study. From the 714 patients presenting 
with mild acute respiratory distress syndrome (ARDS) in the Large Observational Study to Understand the Global Impact of 
Severe Acute Respiratory Failure (LUNG SAFE), 601 fulfilled the criteria for inclusion, and 580 had data allowing classification in 
the defined categories after day 1 (D1; green box). *Twenty-one not in the intensive care unit (ICU) at ARDS day 2 (D2): 12 died, 
5 were transferred to another ICU, and 4 were discharged alive from the ICU. ECMO, extracorporeal membrane oxygenation; 
FIO2, fraction of inspired oxygen; LST, life-sustaining treatment.
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Table 1. Patients’ Baseline Characteristics and Outcomes According to Their Evolution Categories
 
All
N = 580
Improving
N = 103
Persisting
N = 210
Worsening
N = 267 P value N
Baseline       
  Age, mean ± SD, yr 61 ± 17 61 ± 18 61 ± 17 61 ± 16 0.884 580
  Weight, mean ± SD, kg 75.9 ± 20.0 72.8 ± 18.8 75.5 ± 17.3 77.4 ± 22.1 0.142 545
  Female sex (%) 214 (36.9) 29 (28.2) 81 (38.6) 104 (39.0) 0.128 580
Comorbidities, No. (%)       
  Diabetes 121 (20.9) 17 (16.5) 41 (19.5) 63 (23.6) 0.270 580
  COPD 110 (19.0) 23 (22.3) 31 (14.8) 56 (21.0) 0.144 580
  Chronic renal failure 56 (9.7) 13 (12.6) 17 (8.1) 26 (9.7) 0.443 580
  Immunosuppression 116 (20.0) 16 (15.5) 44 (21.0) 56 (21.0) 0.458 580
  Chronic heart failure 60 (10.3) 10 (9.7) 17 (8.1) 33 (12.4) 0.307 580
  Chronic liver failure 20 (3.4) 5 (4.9) 7 (3.3) 8 (3.0) 0.657 580
Type of admission, No. (%)     0.013 580
  Medical 385 (66.4) 60 (58.3) 136 (64.8) 189 (70.8)   
  Postoperative (elective) 47 (8.1) 12 (11.7) 19 (9.0) 16 (6.0)   
  Surgical 112 (19.3) 27 (26.2) 46 (21.9) 39 (14.6)   
  Trauma 36 (6.2) 4 (3.9) 9 (4.3) 23 (8.6)   
Risk factor for ARDS, No. (%)       
  Pneumonia 287 (49.5) 40 (38.8) 98 (46.7) 149 (55.8) 0.008 580
  Extrapulmonary sepsis 113 (19.5) 20 (19.4) 48 (22.9) 45 (16.9) 0.259 580
  Aspiration 85 (14.7) 24 (23.3) 30 (14.3) 31 (11.6) 0.017 580
  Trauma 35 (6.0) 5 (4.9) 11 (5.2) 19 (7.1) 0.595 580
  Pancreatitis 12 (2.1) 1 (1.0) 4 (1.9) 7 (2.6) 0.743 580
  Pulmonary contusion 26 (4.5) 5 (4.9) 8 (3.8) 13 (4.9) 0.863 580
  Pulmonary vasculitis 5 (0.9) 1 (1.0) 3 (1.4) 1 (0.4) 0.415 580
  Noncardiogenic shock 45 (7.8) 8 (7.8) 15 (7.1) 22 (8.2) 0.906 580
  Overdose 14 (2.4) 5 (4.9) 5 (2.4) 4 (1.5) 0.186 580
  TRALI 27 (4.7) 5 (4.9) 12 (5.7) 10 (3.7) 0.588 580
  No identified risk factor 53 (9.1) 12 (11.7) 19 (9.0) 22 (8.2) 0.593 580
First day of ARDS       
  SOFA adjusted, mean ± SD 8.6 ± 3.6 8.0 ± 3.4 8.3 ± 3.6 8.9 ± 3.7 0.049 580
  Nonpulmonary SOFA, mean ± SD 6.4 ± 3.7 5.9 ± 3.5 6.2 ± 3.7 6.8 ± 3.8 0.037 576
  PaCO2, mean ± SD, mmHg 42 ± 10 41 ± 8 42 ± 10 42 ± 11 0.653 579
  pH, mean ± SD 7.36 ± 0.10 7.38 ± 0.09 7.37 ± 0.09 7.36 ± 0.11 0.104 578
  Fio2, median (IQR) 0.4 (0.4, 0.5) 0.4 (0.4, 0.5) 0.4 (0.4, 0.5) 0.4 (0.4, 0.6) 0.002 580
  VT, mean ± SD, ml/kg PBW 7.8 ± 1.7 7.7 ± 1.6 7.8 ± 1.7 7.9 ± 1.7 0.715 549
 PaO2/Fio2 ratio, mean ± SD, mmHg 246 ± 28 251 ± 29 248 ± 28 242 ± 27 0.004 580
  Total respiratory rate, mean ± SD, 1/min 19 ± 6 18 ± 6 19 ± 5 20 ± 6 0.078 576
  PEEP, mean ± SD, cm H2O 7 ± 36 7 ± 2 7 ± 3 8 ± 3 0.011 580
  Plateau pressure, mean ± SD, cm H2O 21 ± 6 19 ± 5 21 ± 5 21 ± 6 0.423 163
  Peak inspiratory pressure, mean ± SD, cm H2O 25 ± 9 22 ± 8 25 ± 9 26 ± 8 0.001 560
  Standardized minute ventilation, mean ± SD, l/min 9.4 ± 3.5 8.9 ± 2.8 9.3 ± 3.4 9.7 ± 3.8 0.134 569
Outcome       
  Clinician recognition of ARDS, No. (%) 292 (50.3) 30 (36.9) 108 (51.4) 146 (54.7) 0.008 580
  Decision of withholding or withdrawing life-sustaining 
treatments, No. (%)
105 (18.1) 7 (6.8) 37 (17.6) 61 (22.8) 0.002 580
  Duration of mechanical ventilation, median (IQR), days 8 (4, 14) 3 (2, 5) 7 (4, 14) 11 (6, 18) < 0.001 550
  Ventilator-free days, median (IQR), days 18 (0, 24) 25 (22, 26) 19 (0, 24) 9 (0, 20) < 0.001 550
  ICU length of stay, median (IQR), days 11 (6, 19) 6 (4, 10) 10 (7, 19) 14 (8, 22) < 0.001 580
  ICU mortality, No. (%) 142 (24.5) 8 (7.8) 45 (21.4) 89 (33.3) < 0.001 580
  Hospital length of stay, median (IQR), days 19 (11, 37) 17 (10, 32) 21 (12, 42) 19 (11, 37) 0.104 564
  Hospital mortality, No. (%) 172 (29.9) 10 (9.9) 63 (30.0) 99 (37.4) < 0.001 576
P values represent comparisons across the evolution categories for each variable. For all sequential organ failure assessment (SOFA) scores for which data 
points were missing, this value was omitted, and the denominator was adjusted accordingly. The nonpulmonary SOFA score and the pulmonary component 
of the score were omitted, and the denominator was adjusted accordingly. Plateau pressure values are limited to patients in whom this value was reported 
and in whom either an assist control mode was used or in whom a control mode permitting spontaneous ventilation was used. Standardized minute ventila-
tion = minute ventilation × Paco2/40 mmHg. Ventilator-free days: calculated as the number of days from weaning from invasive ventilation to day 28. Patients 
who died before weaning were considered to have a ventilator-free day value of 0. Clinical recognition of acute respiratory distress syndrome (ARDS): on the 
day of inclusion, investigators were asked whether the patient presented ARDS. At the time patient exited the study, the investigators were asked whether 
the patient presented ARDS at any stage during his/her intensive care unit (ICU) stay. ARDS was deemed to have been clinician-recognized if either question 
was answered positively. Four patients had missing status at hospital discharge or day 90.
COPD, chronic obstructive pulmonary disease; Fio2, fraction of inspired oxygen; IQR, interquartile range; PBW, predicted body weight; PEEP, positive end-
expiratory pressure; TRALI, transfusion-related acute lung injury; VT, tidal volume. 
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Patients who died in the hospital had more comorbidities, 
including a higher rate of diabetes, immunosuppression, 
and chronic liver failure (table 5 in the Supplemental Digi-
tal Content, http://links.lww.com/ALN/B814). Their main 
cause for admission was more frequently medical than surgi-
cal or trauma, and they had a higher rate of pneumonia as a 
risk factor for ARDS. They also displayed a more severe base-
line severity, with higher sequential organ failure assessment 
scores, lower arterial pH, and fewer patients with improving 
oxygenation the day after ARDS onset.
Kaplan–Meier hospital survival curves for each cat-
egory of ARDS evolution the day after ARDS onset (fig. 3) 
Fig. 2. Evolution of PaO2/fraction of inspired oxygen (FIO2; A), tidal volume (B), and positive end-expiratory pressure (PEEP; C) in 
the first week after acute respiratory distress syndrome (ARDS) onset according to the evolution group. (A) Evolution of PaO2/FIO2 
and comparison between the improving (green), persisting (orange), and worsening (red) categories. On day 1,  
PaO2/FIO2 was significantly lower in the worsening group as compared to the improving group (P = 0.009) and the persisting group 
(P = 0.031). Each following day, PaO2/FIO2 was significantly different between each of the three groups with a gradual increase 
from the worsening to the persisting and to the improving group. As compared to day 1, Pao2/FIO2 on day 2 significantly de-
creased in the worsening group and then remained stable, whereas it increased in the improving and persisting groups. (B) Evo-
lution of tidal volume and comparison between the improving (green), persisting (orange), and worsening (red) categories. Tidal 
volume was similar between groups at day 1 and remained similar each day of data collection. Within each group, tidal volume 
also remained similar to the initial one at each day of follow-up.  
(Continued)
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demonstrated different survival probability overall (P < 
0.001) and comparing the improving group to the persisting 
group (P < 0.001) or the worsening group (P = 0.043) but 
not comparing the worsening group to the persisting group 
(P = 0.649).
In a multivariable logistic regression, higher age, medical 
history of diabetes or immunosuppression, higher nonpul-
monary admission sequential organ failure assessment scores, 
and extrapulmonary sepsis as a risk factor for ARDS were 
associated with higher risk of death in the hospital, whereas 
admission for surgery or being in the group with improv-
ing oxygenation the day after ARDS onset was associated 
with increased hospital survival (table 4). The model showed 
good fit (P = 0.749 on the Hosmer–Lemeshow goodness-of-
fit test). As a sensitivity analysis, both the Cox proportional 
hazard model and the time-varying Cox model found the 
same factors as the logistic regression associated with hos-
pital mortality (tables 6 and 7 in the Supplemental Digital 
Content, http://links.lww.com/ALN/B814).
Discussion
This analysis of the characteristics and evolution of patients 
classified as mild ARDS at initial presentation revealed sev-
eral new and relevant results. First, despite being in the low-
est severity group of ARDS, patients with initial mild ARDS 
had a hospital mortality of 30%. Second, 82% had persistent 
ARDS, whereas 46% worsened within the first week; this 
latter group had a mortality of 37%. Third, no modifiable 
factor was independently associated with this deterioration. 
Taken together, these findings demonstrate that patients 
with initial “mild” ARDS are a critically ill cohort with a 
high risk of worsening ARDS severity and a high mortality 
that may require greater attention and/or preventive mea-
sures. These findings illustrate the importance of raising cli-
nicians’ awareness regarding patients with mild ARDS and 
considering them for inclusion in research studies with a spe-
cific focus on preventing worsening of ARDS.
Population Definition
Patients initially presenting with mild ARDS are a poorly 
characterized cohort. Relatively few epidemiologic stud-
ies7,9–11,13,19–21 included patients with mild ARDS, and they 
found a wide mortality range from 15%9 to 42%19 and even 
higher in burn22 and cancer patients.23 None of these studies 
provided a daily reassessment of the patients’ management 
and evolution. More than 80% of the patients in our cohort 
continued to have ARDS on the days after onset, corroborat-
ing the rationale of including the mild category in the most 
recent definition of ARDS.1 Despite a high global mortality 
of 30%, only half of them were recognized as having ARDS 
by their clinicians, highlighting the need to better character-
ize and understand this group to ultimately optimize their 
management. Of importance, hospital mortality was rela-
tively low in the improving group (10%) as compared to the 
persisting and worsening group (30 and 37%, respectively), 
emphasizing the importance of monitoring ARDS evolution 
over the first week. Evolution of oxygenation in the first week 
was the main criterion of the group definitions; thus it was 
Fig. 2. (Continued ). (C) Evolution of PEEP and comparison between the improving (green), persisting (orange), and worsen-
ing (red) categories. On days 1, 2, and 3, PEEP was significantly higher in the worsening group as compared to the improving 
groups. Every day of data collection except on day 1, PEEP was higher in the worsening group as compared to the persisting 
groups. In the persisting groups, PEEP decreased from day 1 to day 2 and remained stable the following days. Detailed P  values 
are shown in tables 2–4 in the Supplemental Digital Content (http://links.lww.com/ALN/B814). *P < 0.05 for overall comparison; 
†P < 0.05 for two-by-two comparison; ‡P < 0.05 versus day 1 for the same group; §P < 0.05 versus day 2 for the same group; ||P 
< 0.05 versus day 3 for the same group; #P < 0.05 versus day 5 for the same group. PBW, predicted body weight.
Copyright © 2018, the American Society of Anesthesiologists, Inc. Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Anesthesiology 2018; XXX:00-00 8 Pham et al.
Mild Acute Respiratory Distress Syndrome Evolution
Table 2. Characteristics and Outcome of Worsening versus Nonworsening Patients
 
Nonworsening, 
N = 313
Worsening,  
N = 267 P value N
Baseline     
  Age, mean ± SD, yr 61 ± 17 61 ± 16 0.659 580
  Weight, mean ± SD, kg 74.6 ± 17.8 77.4 ± 22.1 0.109 545
  Female sex (%) 110 (35.1) 104 (39.0) 0.389 580
Comorbidities, No. (%)     
  Diabetes 58 (18.5) 63 (23.6) 0.163 580
  COPD 54 (17.3) 56 (21.0) 0.302 580
  Chronic renal failure 30 (9.6) 26 (9.7) 1.000 580
  Immunosuppression 60 (19.2) 56 (21.0) 0.662 580
  Chronic heart failure 27 (8.6) 33 (12.4) 0.182 580
  Chronic liver failure 12 (3.8) 8 (3.0) 0.747 580
Type of admission, No. (%)   0.002  
  Medical 196 (62.6) 189 (70.8)   
  Postoperative (elective) 31 (9.9) 16 (6.0)   
  Surgical 73 (23.3) 39 (14.6)   
  Trauma 13 (4.2) 23 (8.6)   
Risk factor for ARDS, No. (%)     
  Pneumonia 138 (44.1) 149 (55.8) 0.006 580
  Extrapulmonary sepsis 68 (21.7) 45 (16.9) 0.170 580
  Aspiration 54 (17.3) 31 (11.6) 0.072 580
  Trauma 16 (5.1) 19 (7.1) 0.403 580
  Pancreatitis 5 (1.6) 7 (2.6) 0.568 580
  Pulmonary contusion 13 (4.2) 13 (4.9) 0.831 580
  Pulmonary vasculitis 4 (1.3) 1 (0.4) 0.381 580
  Noncardiogenic shock 23 (7.3) 22 (8.2) 0.807 580
  Overdose 10 (3.2) 4 (1.5) 0.291 580
  TRALI 17 (5.4) 10 (3.7) 0.446 580
  No identified risk factor 31 (9.9) 22 (8.2) 0.583 580
First day of ARDS     
  SOFA adjusted, mean ± SD 8.2 ± 3.5 8.9 ± 3.7 0.018 580
  Nonpulmonary SOFA, mean ± SD 6.1 ± 3.6 6.8 ± 3.8 0.013 576
  PaCO2, mean ± SD, mmHg 42 ± 9 42 ± 11 0.561 579
  pH, mean ± SD 7.37 ± 0.09 7.36 ± 0.11 0.050 578
  FIO2, median (IQR) 0.4 (0.4; 0.5) 0.4 (0.4; 0.6) <0.001 580
  VT, mean ± SD, ml/kg PBW 7.8 ± 1.7 7.9 ± 1.7 0.415 549
  PaO2/FIO2 ratio, mean ± SD, mmHg 249 ± 28 242 ± 27 0.001 580
  Total respiratory rate, mean ± SD, 1/min 19 ± 6 20 ± 6 0.061 576
  PEEP, mean ± SD, cm H2O 7 ± 2 8 ± 3 0.007 580
  Plateau pressure, mean ± SD, cm H2O 21 ± 5 21 ± 6 0.937 163
  Peak inspiratory pressure, mean ± SD, cm H2O 24 ± 9 26 ± 8 0.016 560
  Standardized minute ventilation, mean ± SD, l/min 9.1 ± 3.2 97 ± 3.7 0.076 569
Outcome     
  Clinician recognition of ARDS, No. (%) 146 (46.6) 146 (54.7) 0.065 580
  Decision of withholding or withdrawing life-sustaining treatments, 
No. (%)
44 (14.1) 61 (22.8) 0.008 580
  Duration of mechanical ventilation, median (IQR), days 5 (3, 11) 11 (6, 18) < 0.001 550
  Ventilator-free days, median (IQR), days 22 (6, 25) 9 (0, 20) < 0.001 550
  ICU length of stay, median (IQR), days 9 (5, 17) 14 (8, 22) < 0.001 580
  ICU mortality, No. (%) 53 (16.9) 89 (33.3) < 0.001 580
  Hospital length of stay, median (IQR), days 20 (11, 38) 19 (11, 37) 0.950 564
  Hospital mortality, No. (%) 73 (23.5) 99 (37.4) < 0.001 576
The P value represents comparisons across the evolution categories for each variable. For all sequential organ failure assessment (SOFA) scores for which 
data points were missing, this value was omitted, and the denominator was adjusted accordingly. The nonpulmonary SOFA score and the pulmonary 
component of the score were omitted, and the denominator was adjusted accordingly. Plateau pressure values are limited to patients in whom this value 
was reported and in whom either an assist control mode was used or in whom a control mode permitting spontaneous ventilation was used. Standardized 
minute ventilation = minute ventilation × PaCO2/40 mmHg. Ventilator-free days: calculated as the number of days from weaning from invasive ventilation to 
day 28. Patients who died before weaning were considered to have a ventilator-free day value of 0.
ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; FIO2, fraction of inspired oxygen; ICU, intensive care unit; IQR, 
interquartile range; PBW, predicted body weight; PEEP, positive end-expiratory pressure; TRALI, transfusion related acute lung injury; VT, tidal volume.
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expected that patients with worsening oxygenation within 
this relatively long period would have a poorer outcome. To 
avoid this bias, we only used classification at day 2 of ARDS 
for mortality analyses.
Risks Factors for Progression of ARDS
Predicting the evolution of patients with initial mild 
ARDS facilitates identification of patients that may benefit 
from specific managements or closer monitoring, as well 
as optimizing inclusion criteria selection in future studies. 
As previously described, trauma and pneumonia were the 
ARDS risk factors independently associated with worsen-
ing severity over the first week.8,24–26 We could not iden-
tify any modifiable factor independently associated with 
worsening oxygenation. Most of the literature on patients’ 
oxygenation evolution was obtained in patients at risk of 
developing ARDS,27 but we lack evidence regarding the 
strategy that would avoid worsening of patients presenting 
mild ARDS. Similar to ARDS prevention, an optimized 
management combining protective ventilation, restric-
tive fluids and transfusion management, and etiologic 
treatment seems appropriate but still has to be tested.28,29 
Given the high rate of patients worsening within the first 
week in our cohort, patients with mild ARDS appear to 
be an appropriate population to test such interventions in 
the future.
Patients’ Initial Characteristics, Severity, and Ventilation 
Parameters
Contrasting with previous literature, diabetes was associated 
with mortality in our cohort of patients with mild ARDS. 
Diabetes may decrease the risk of developing ARDS.30,31 In 
patients with ARDS, diabetes either had no effect32,33 or was 
associated with a better outcome.34 Chronic diseases and 
complication of diabetes such as kidney failure or cardiovas-
cular disease may play a more important role in patients with 
initial mild ARDS as opposed to patients with more severe 
hypoxemia.
Illness severity at ARDS onset, whether related to the lung 
injury (lower PaO2/FIO2 and higher peak inspiratory pressure) 
or other organ dysfunctions (higher nonpulmonary sequen-
tial organ failure assessment), was associated with worsening 
oxygenation. The sequential organ failure assessment score 
has consistently been reported as a good predictor for out-
comes in critically ill patients.35–38 The association between 
driving pressure or plateau pressure and mortality has been 
previously described.39,40 These variables were reported only 
in 28% of the patients either because the mode of ventila-
tion did not allow a reliable assessment (patients showing 
evidence of spontaneous breathing) or because they were 
not measured. We used the peak inspiratory pressure as a 
surrogate of airway pressures, because this is a measure-
ment available in all modes of mechanical ventilation, and 
its association with mortality was shown in a recent cohort 
of ventilated patients.41 Peak inspiratory pressure increased 
sequentially with severity of evolution categories, and in 
multivariable analysis, higher peak inspiratory pressure was 
associated with an increased risk of being in the group with 
worsening evolution.
Tidal volumes and PEEP are potentially modifiable fac-
tors in the management of patients with ARDS.42–45 In 
accordance with the observational study design, no rec-
ommendations regarding ventilator settings were given to 
investigators, and mean tidal volumes around 8 ml/kg pre-
dicted body weight used in this study were higher than the 
6 ml/kg usually recommended.42,46 Modes of ventilation 
Table 3. Multivariable Analysis of Factors Associated with Worsening ARDS
 Odds Ratio 95% CI P value
Admission for trauma 2.74 1.33–5.88 0.007
Pneumonia 1.69 1.19–2.40 0.004
Nonpulmonary SOFA score (for 1 point) 1.07 1.02–1.12 0.005
PaO2/FIO2 ratio (per decrease of 10 mmHg) 1.09 1.03–1.17 0.004
Peak inspiratory pressure (for 1 cmH2O) 1.02 1.00–1.04 0.046
ARDS, acute respiratory distress syndrome; FIO2, fraction of inspired oxygen; SOFA, sequential organ failure assessment.
Table 4. Multivariable Analysis of Factors Associated with Hospital Death
 Odds Ratio 95% CI P value
Age (for 1 year) 1.03 1.02–1.05 < 0.001
Diabetes 1.75 1.09–2.481 0.018
Immunosuppression 2.20 1.37–3.55 < 0.001
Nonpulmonary SOFA score (for 1 point) 1.14 1.08–1.22 < 0.001
Extrapulmonary sepsis 1.99 1.19–3.34 0.009
Surgical cause of admission 0.39 0.24–0.64 < 0.001
Improving oxygenation in the first 24 h 0.57 0.35–0.91 0.020
SOFA, sequential organ failure assessment.
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allowing spontaneous breathing were used for more than 
40% of patients on the day of ARDS onset. Clinicians toler-
ated these modes and higher tidal volumes maybe because 
they considered patients with mild ARDS less severe than 
more hypoxemic patients. We could not find any associa-
tion between tidal volume and outcomes (evolution of oxy-
genation or mortality) likely because despite being higher 
than recommended, tidal volumes were in a narrow range 
(7.8 ± 1.7 ml/kg predicted body weight). It is still unclear 
whether larger tidal volumes generated by patients should be 
tolerated in less severe patients or are harmful47–49; however, 
most of the patients had tidal volumes remaining in reason-
able ranges, well below the demonstrated injurious 12 ml/
kg predicted body weight.42 Patients in the worsening group 
received higher PEEP, but this was probably confounded by 
severity because PEEP was not found to be associated with 
worsening of increased mortality in multivariable analyses. 
Although we have evidence for the benefit of higher PEEP 
in moderate to severe ARDS and in the overall LUNG SAFE 
patient cohort,50 the impact of PEEP in mild ARDS remains 
unclear.51,52
Outcome from ARDS
Early improvement (PaO2/FIO2 more than 300 mmHg or 
extubation) was associated with a better survival, whereas 
patients in the persisting and worsening groups had a com-
parable evolution and worse outcome. It has been previ-
ously proposed to reassess ARDS criteria after a stabilization 
period3 or standardizing ventilation parameters to better pre-
dict outcomes.53–55 However, these authors mainly focused 
on moderate to severe ARDS. In our mild ARDS cohort, 
13.6% of the patients with an initial improvement on the 
day after ARDS onset worsened later during their intensive 
care unit stay. We have recently demonstrated that reclassify-
ing ARDS severity at day 2 identifies a subgroup with severe 
ARDS at day 2 as being at high risk for mortality.56 In con-
trast, reclassifying ARDS severity at day 2 regardless of initial 
severity in the whole LUNG SAFE ARDS cohort showed 
limited additional predictive value.56 We demonstrate here 
that most patients with initial mild ARDS continue to have 
ARDS over the course of the first week, with many progress-
ing to higher-severity ARDS, and have a high mortality. This 
highlights that patients with initial mild ARDS constitute a 
critically ill group with a high mortality that require greater 
attention.
Limitations
By design, observational studies cannot adjust for unmea-
sured confounders and rely on the quality of the data col-
lected by the investigators. However, most of the common 
important data for characterization of patients with ARDS 
were available; the amount of missing data at baseline was low 
except for plateau pressure, and outliers were confirmed or 
corrected by contacting site investigators. The data were col-
lected only once a day, which makes it impossible to get more 
granular information. We acknowledged these limitations 
when designing LUNG SAFE. We deliberately balanced 
the quantity of data collected with investigator workload to 
enhance feasibility. Here, we provide a real-life prospective 
assessment of nonselected patients with mild ARDS using the 
Fig. 3. Probability of hospital survival by day 2 evolution category. Kaplan–Meier curves comparing the probability of survival 
in the improving (green), persisting (orange), and worsening (red) groups. Log-rank tests show an overall difference between 
groups and a higher probability of hospital survival in the improving group as compared to the persisting group or to the worsen-
ing group. These Kaplan Meier analysis included the 545 patients with data available for classification of oxygenation evolution 
at day 2 and vital status at hospital discharge. *Log-rank test for evolution category comparisons: P < 0.001 overall; P < 0.001 
persisting versus improving; P = 0.042 worsening versus improving; and P = 0.649 worsening versus persisting.
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most rigorous methods of the Strengthening the Reporting of 
Observational Studies in Epidemiology (STROBE).18
Conclusions
Most of the patients initially presenting with mild ARDS 
continue to fulfill criteria over the following days, and nearly 
half of them worsen in terms of ARDS severity category 
over the first week. Their mortality is high, particularly in 
patients with worsening ARDS, emphasizing the need for 
greater clinical attention and the necessity to include them 
in specific clinical trials and to develop strategies to prevent 
worsening of ARDS severity in these patients.
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Appendix: LUNG SAFE Investigators
LUNG SAFE Steering Committee: Antonio Pesenti, M.D., John 
G. Laffey, M.D., Ph.D., Laurent Brochard, M.D., Andres Esteban, 
M.D., Luciano Gattinoni, M.D., F.R.C.P., Frank van Haren, M.D., 
Ph.D., Anders Larsson, M.D., Ph.D., Daniel F. McAuley, M.D., 
Ph.D., Marco Ranieri, M.D., Gordon Rubenfeld, M.D., M.Sc., B. 
Taylor Thompson, M.D., Hermann Wrigge, M.D., Ph.D., Arthur 
S. Slutsky, M.D.
LUNG SAFE Executive Committee: John G. Laffey, Giacomo 
Bellani, Tài Pham, Eddy Fan
LUNG SAFE National Coordinators: Argentina: Fernando Rios; 
Australia/New Zealand: Frank Van Haren; Belgium: Thierry Sot-
tiaux, Pieter Depuydt; Bolivia: Fredy S. Lora; Brazil: Luciano Cesar 
Azevedo; Canada: Eddy Fan; Chile: Guillermo Bugedo; China: 
Haibo Qiu; Colombia: Marcos Gonzalez; Costa Rica: Juan Silesky; 
Czech Republic: Vladimir Cerny; Denmark: Jonas Nielsen; Ecua-
dor: Manuel Jibaja; France: Tài Pham; Germany: Hermann Wrigge; 
Greece: Dimitrios Matamis; Guatemala: Jorge Luis Ranero; India: 
Pravin Amin; Iran: S.M. Hashemian; Ireland: Kevin Clarkson; 
Italy: Giacomo Bellani; Japan: Kiyoyasu Kurahashi; Mexico: Asis-
clo Villagomez; Morocco: Amine Ali Zeggwagh; Netherlands: Leo 
M. Heunks; Norway: Jon Henrik Laake; Philippines: Jose Emman-
uel Palo; Portugal: Antero do Vale Fernandes; Romania: Dorel 
Sandesc; Saudi Arabia: Yaasen Arabi; Serbia: Vesna Bumbasierevic; 
Spain: Nicolas Nin, Jose A. Lorente; Sweden: Anders Larsson; 
Switzerland: Lise Piquilloud; Tunisia: Fekri Abroug; United King-
dom: Daniel F. McAuley, Lia McNamee; Uruguay: Javier Hurtado; 
United States: Ed Bajwa; Venezuela: Gabriel Démpaire
LUNG SAFE Site Investigators (by country): 
Albania: Uhc Mother Theresa, Tirana: Hektor Sula, Lordian 
Nunci; University Hospital Shefqet Ndroqi, Tirana: Alma Cani
Argentina: Clinica de Especialidades, Villa Maria: Alan Zazu; 
Hospital Julio C. Perrando, Resistencia: Christian Dellera, Carolina 
S. Insaurralde; Sanatorio Las Lomas, San Isidro, Buenos Aires: Risso 
V. Alejandro; Sanatorio de La Trinidad San Isidro, San Isidro: Julio 
Daldin, Mauricio Vinzio; Hospital Español de Mendoza, Godoy 
Cruz-Mendoza: Ruben O. Fernandez; Hospital del Centenario, 
Rosario: Luis P. Cardonnet, Lisandro R. Bettini; San Antonio, 
Gualeguay, Entre Rios: Mariano Carboni Bisso, Emilio M. Osman; 
Cemic, Buenos Aires: Mariano G. Setten, Pablo Lovazzano; Hospital 
Universitrario Austral, Pilar: Javier Alvarez, Veronica Villar; Hospital 
Por + Salud, Pami Dr. Cesar Milstein, Buenos Aires: Norberto C. 
Pozo, Nicolas Grubissich; Sanatorio Anchorena, Buenos Aires: Gus-
tavo A. Plotnikow, Daniela N. Vasquez; Sanatorio de La Trinidad 
Mitre, Buenos Aires: Santiago Ilutovich, Norberto Tiribelli; Hospi-
tal Luis Lagomaggiore, Mendoza: Ariel Chena, Carlos A. Pellegrini; 
Hospital Interzonal General de Agudos, San Martín, La Plata: María 
G. Saenz, Elisa Estenssoro; Hospital Misericordia, Cordoba: Matias 
Brizuela, Hernan Gianinetto; Sanatorio Juncal, Temperley: Pablo E. 
Gomez, Valeria I. Cerrato; Hospital D.F. Santojanni, Buenos Aires: 
Marco G. Bezzi, Silvina A. Borello; Hospital Alejandro Posadas, 
Buenos Aires: Flavia A. Loiacono, Adriana M. Fernandez
Australia: St. Vincent’s Hospital, Sydney: Serena Knowles, 
Claire Reynolds; St. George Public Hospital, Kogarah: Deborah 
M. Inskip, Jennene J. Miller; Westmead Hospital, Westmead: Jing 
Kong, Christina Whitehead; Flinders Medical Center, Bedford 
Park: Shailesh Bihari; John Hunter Hospital, Newcastle: Aylin 
Seven, Amanda Krstevski; Canberra Hospital, Garran: Helen J. 
Rodgers, Rebecca T. Millar; Calvary Mater Newcastle, Waratah: 
Toni E. Mckenna, Irene M. Bailey; Cabrini Hospital, Melbourne: 
Gabrielle C. Hanlon; Liverpool Hospital, Liverpool: Anders Ane-
man, Joan M. Lynch; Coffs Harbour Health Campus, Coffs Har-
bour: Raman Azad, John Neal; Sir Charles Gairdner Hospital, 
Nedlands: Paul W. Woods, Brigit L. Roberts; Concord Hospital, 
Concord: Mark R. Kol, Helen S. Wong
Austria: General Hospital of Vienna/Medical University of 
Vienna, Vienna: Katharina C. Riss, Thomas Staudinger
Belgium: Cliniques Universitaires St. Luc, Université 
Catholique de Louvain, Brussels: Xavier Wittebole, Caroline Ber-
ghe; Center Hospitalier Universitaire Dinant-Godinne, Yvoir: 
Pierre A. Bulpa, Alain M. Dive; Acuut Ziekenhuis Sint Augustinus 
Veurne, Veurne: Rik Verstraete, Herve Lebbinck; Ghent University 
Hospital, Ghent: Pieter Depuydt, Joris Vermassen; University Hos-
pitals Leuven, Leuven: Philippe Meersseman, Helga Ceunen
Brazil: Hospital Renascentista, Pouso Alegre: Jonas I. Rosa, Dan-
iel O. Beraldo; Vitoria Apart Hospital, Serra: Claudio Piras, Ade-
nilton M. Rampinelli; Hospital Das Clinicas, São Paulo: Antonio P. 
Nassar, Jr.; Hospital Geral Do Grajaù, São Paulo: Sergio Mataloun, 
Marcelo Moock; Evangelical Hospital, Cachoeiro de Itapemirim/
Espírito Santo: Marlus M. Thompson, Claudio H. Gonçalves; Hos-
pital Moinhos de Vento, Porto Alegre: Ana Carolina P. Antônio, 
Aline Ascoli; Hospital Alvorada Taguatinga, Taguatinga: Rodrigo 
S. Biondi, Danielle C. Fontenele; Complexo Hospitalar Mngabeira 
Tarcisio Burity, Joao Pessoa: Danielle Nobrega, Vanessa M. Sales
Brunei: Raja Isteri Pengiran Anak Saleha Hospital, Bandar 
Seri Begawan: Ahmad Yazid Bin HJ Abul Wahab, Maizatul Ismail, 
Suresh Shindhe
Canada: Medical-Surgical Intensive Care Unit of St. Michael’s 
Hospital, Toronto: John Laffey, Francois Beloncle; St. Joseph’s Health 
Center, Toronto: Kyle G. Davies, Rob Cirone; Sunnybrook Health 
Sciences Center, Toronto: Venika Manoharan, Mehvish Ismail; 
Toronto Western Hospital, Toronto: Ewan C. Goligher, Mandeep 
Jassal; Medical Surgical Intensive Care Unit of the Toronto Gen-
eral Hospital, Toronto: Erin Nishikawa, Areej Javeed; Cardiovascu-
lar Intensive Care Unit of St. Michael’s Hospital, Toronto: Gerard 
Curley, Nuttapol Rittayamai; Cardiovascular Intensive Care Unit of 
the Toronto General Hospital, Toronto: Matteo Parotto, Niall D. 
Ferguson; Mount Sinai Hospital, Toronto: Sangeeta Mehta, Jenny 
Knoll; Trauma-Neuro Intensive Care Unit of St. Michael’s Hospital, 
Toronto: Antoine Pronovost, Sergio Canestrini
Chile: Hospital Clínico Pontificia Universidad Católica de Chile, 
Santiago: Alejandro R. Bruhn, Patricio H. Garcia; Hospital Militar de 
Santiago, Santiago: Felipe A. Aliaga, Pamela A. Farías; Clinica Davila, 
Santiago: Jacob S. Yumha; Hospital Guillermo Grant Benavente, 
Concepcion: Claudia A. Ortiz, Javier E. Salas; Clinica Las Lilas, San-
tiago: Alejandro A. Saez, Luis D. Vega; Hospital Naval Almirante Nef, 
Viña del Mar: Eduardo F. Labarca, Felipe T. Martinez; Hospital Luis 
Tisné Brousse, Penanolen: Nicolás G. Carreño, Pilar Lora
China: Second Affiliated Hospital of Harbin Medical Univer-
sity, Harbin: Haitao Liu; Nanjing Zhong-da Hospital, Southeast 
University, Nanjing: Haibo Qiu, Ling Liu; First Affiliated Hospi-
tal of Anhui Medical University, Hefei: Rui/Tang, Xiaoming Luo; 
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Peking University People’s Hospital, Beijing: Youzhong An, Huiy-
ing Zhao; Fourth Affiliated Hospital of Harbin Medical University, 
Harbin: Yan Gao, Zhe Zhai; Nanjing Jiangbei People’s Hospital 
Affiliated to Medical School of Southeast University, Nanjing: 
Zheng L. Ye, Wei Wang; First Affiliated Hospital of Dalian Medi-
cal University, Dalian: Wenwen Li, Qingdong Li; Subei People’s 
Hospital of Jiangsu Province, Yanghzou: Ruiqiang Zheng; Jinling 
Hospital, Nanjing: Wenkui Yu, Juanhong Shen; Urumqi General 
Hospital, Urumqi: Xinyu Li; Intensive Care Unit, First Affiliated 
Hospital of Wanna Medical College, Yijishan Hospital, Wuhu: Tao 
Yu, Weihua Lu; Sichuan Provincial People’s Hospital, Chengdu: 
Ya Q. Wu, Xiao B. Huang; Hainan Province People’s Hospital, 
Haikou: Zhenyang He; People’s Hospital of Jiangxi Province, 
Nanchang: Yuanhua Lu; Qilu Hospital of Shandong University, 
Jinan: Hui Han, Fan Zhang; Zhejiang Provincial People’s Hospital, 
Hangzhou: Renhua Sun; First Affiliated Hospital of Bengbu Medi-
cal College, Bengbu, Anhui: Hua X. Wang, Shu H. Qin; Nanjing 
Municipal Government Hospital, Nanjing: Bao H. Zhu, Jun Zhao; 
First Hospital of Lanzhou University, Lanzhou: Jian Liu, Bin Li; 
First Affiliated Hospital of Chongqing University of Medical Sci-
ence, Chongqing: Jing L. Liu, Fa C. Zhou; Xuzhou Central Hos-
pital, Xuzhou: Qiong J. Li, Xing Y. Zhang; First People’s Hospital 
of Foshan, Foshan: Zhou Li-Xin, Qiang Xin-Hua; First Affiliated 
Hospital of Guangxi Medical University, Nanning: Liangyan Jiang; 
Renji Hospital, Shanghai Jiao Tong University School of Medicine, 
Shanghai: Yuan N. Gao, Xian Y. Zhao; First Hospital of Shanxi 
Medical University, Taiyuan: Yuan Y. Li, Xiao L. Li; Shandong 
Provincial Hospital, Jinan: Chunting Wang, Qingchun Yao; Fujian 
Provincial Hospital, Fuzhou: Rongguo Yu, Kai Chen; Henan Pro-
vincial People’s Hospital, Zhengzhou: Huanzhang Shao, Bingyu 
Qin; Second Affiliated Hospital of Kunming Medical University, 
Kunming City: Qing Q. Huang, Wei H. Zhu; Xiangya Hospital, 
Central South University, Changsha: Ai Y. Hang, Ma X. Hua; First 
Affiliated Hospital of Guangzhou Medical University, Guangzhou: 
Yimin Li, Yonghao Xu; People’s Hospital of Hebei Province, Shiji-
azhuang: Yu D. Di, Long L. Ling; Guangdong General Hospital, 
Guangzhou: Tie H. Qin, Shou H. Wang; Beijing Tongren Hospi-
tal, Beijing: Junping Qin; Jiangsu Province Hospital, Nanjing: Yi 
Han, Suming Zhou
Colombia: Fundación Valle del Lili, Cali: Monica P. Vargas
Costa Rica: Hospital San Juan De Dios, San Jose: Juan I. 
Silesky Jimenez, Manuel A. González Rojas, Jaime E. Solis-Que-
sada, Christian M. Ramirez-Alfaro
Czech Republic: University Hospital of Ostrava, Ostrava: Jan 
Máca, Peter Sklienka
Denmark: Aarhus Universitetshospital, Aarhus: Jakob Gjed-
sted, Aage Christiansen; Rigshopitalet: Jonas Nielsen
Ecuador: Hospital Militar, Quito: Boris G. Villamagua, Miguel 
Llano
France: Clinique du Millenaire, Montpellier: Philippe Burtin, 
Gautier Buzancais; Center Hospitalier, Roanne: Pascal Beuret, 
Nicolas Pelletier; Center Hospitalier Universitaire d’Angers, Angers: 
Satar Mortaza, Alain Mercat; Hôpital Marc Jacquet, Melun: Jona-
than Chelly, Sébastien Jochmans; Center Hospitalier Universitaire 
Caen, Caen: Nicolas Terzi, Cédric Daubin; Henri Mondor Hos-
pital, Créteil: Guillaume Carteaux, Nicolas de Prost; Cochin Hos-
pital, Paris: Jean-Daniel Chiche, Fabrice Daviaud; Hôpital Tenon, 
Paris: Tài Pham, Muriel Fartoukh; CH Mulhouse-Emile Muller, 
Mulhouse: Guillaume Barberet, Jerome Biehler; Archet 1 Univer-
sity Hospital, Nice: Jean Dellamonica, Denis Doyen; Hopital Sainte 
Musse, Toulon: Jean-Michel Arnal, Anais Briquet; Hopital Nord–
Réanimation des Détresses Respiratoires et Infections Sévères, 
Marseille: Sami Hraiech, Laurent Papazian; Hôpital Européen 
Georges Pompidou, Paris: Arnaud Follin; Louis Mourier Hospi-
tal, Colombes: Damien Roux, Jonathan Messika; Center Hospit-
alier de Dax, Dax: Evangelos Kalaitzis; Réanimation Médicale, 
Groupe Hospitalier Pitié-Salpêtrière, Paris: Laurence Dangers, Alain 
Combes; Assistance Publique-Hôpitaux de Paris Ambroise Paré, 
Boulogne-Billancourt: Siu-Ming Au; University Hospital Rouen, 
Rouen: Gaetan Béduneau, Dorothée Carpentier; Center Hospital-
ier Universitaire Amiens, Amiens–Salouel: Elie H. Zogheib, Herve 
Dupont; Center Hospitalier Intercommunal Robert Ballanger, 
Aulnay-sous-Bois: Sylvie Ricome, Francesco L. Santoli; Center 
Hospitalier René Dubos, Pontoise: Sebastien L. Besset; Center 
Hospitalier Intercommunal Portes de l’Oise, Beaumont-sur-Oise: 
Philippe Michel, Bruno Gelée; Archet 2 University Hospital, Nice: 
Pierre-Eric Danin, Bernard Goubaux; Center Hospitalier Pierre 
Oudot, Bourgoin Jallieu: Philippe J. Crova, Nga T. Phan; Center 
Hospitalier Dunkerque, Dunkerque: Frantz Berkelmans; Center 
Hospitalier de Belfort Montbéliard, Belfort: Julio C. Badie, Romain 
Tapponnier; Center Hospitalier Emile Muller, Mulhouse: Josette 
Gally, Samy Khebbeb; Hôpital de Hautepierre-Hôpitaux Univer-
sitaires de Strasbourg, Strasbourg: Jean-Etienne Herbrecht, Francis 
Schneider; Center Hospitalier de Dieppe, Dieppe: Pierre-Louis 
M. Declercq, Jean-Philippe Rigaud; Bicetre, Le Kremin–Bicetre: 
Jacques Duranteau, Anatole Harrois; Center Hospitalier Universita-
ire Gabriel Montpied, Clermont-Ferrand: Russell Chabanne, Julien 
Marin; Center Hospitalier Universitaire Estaing, Clermont-Ferrand: 
Charlene Bigot, Sandrine Thibault; Center Hospitalier Intercom-
munal Eure-Seine Evreux, Evreux: Mohammed Ghazi, Messabi 
Boukhazna; Center Hospitalier de Châlons en Champagne, Châlons 
en Champagne: Salem Ould Zein; CH Beauvais, Beauvais: Jack R. 
Richecoeur, Daniele M. Combaux; Center Hospitalier Le Mans, Le 
Mans: Fabien Grelon, Charlene Le Moal; Hôpital Fleyriat, Bourg-
en-Bresse: Elise P. Sauvadet, Adrien Robine; Hôpital Saint Louis, 
Paris: Virginie Lemiale, Danielle Reuter; Service de Pneumologie 
Pitié-Salpétrière, Paris: Martin Dres, Alexandre Demoule; Center 
Hospitalier Gonesse, Gonesse: Dany Goldgran-Toledano; Hôpital 
Croix Rousse, Lyon: Loredana Baboi, Claude Guérin
Germany: St. Nikolaus-Stiftshospital, Andernach: Ralph 
Lohner; Fachkrankenhaus Coswig Gmbh, Coswig: Jens Kraßler, 
Susanne Schäfer; University Hospital Frankfurt, Frankfurt am 
Main: Kai D. Zacharowski, Patrick Meybohm; Department of 
Anesthesia and Intensive Care Medicine, University Hospital of 
Leipzig, Leipzig: Andreas W. Reske, Philipp Simon; Asklepios 
Klinik Langen, Langen: Hans-Bernd F. Hopf, Michael Schuetz; 
Städtisches Krankenhaus Heinsberg, Heinsberg: Thomas Baltus
Greece: Hippokrateion General Hospital of Athens, Athens: 
Metaxia N. Papanikolaou, Theonymfi G. Papavasilopoulou; Gh 
Ahepa, Thessaloniki: Giannis A. Zacharas, Vasilis Ourailogloy; 
Hippokration General Hospital of Thessaloniki, Thessaloniki: Eleni 
K. Mouloudi, Eleni V. Massa; Hospital General of Kavala, Kavala: 
Eva O. Nagy, Electra E. Stamou; Papageorgiou General Hospital, 
Thessaloniki: Ellada V. Kiourtzieva, Marina A. Oikonomou
Guatemala: Hospital General de Enfermedades, Instituto Gua-
temalteco de Seguridad Social, Ciudad de Guatemala: Luis E. Avila; 
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